Fentanyl transdermal system and Flonase drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Fentanyl transdermal system (fentanyl) and Flonase (fluticasone propionate). Common drug interactions include application site pruritus among females and insomnia among males.

The phase IV clinical study analyzes what interactions people have when they take Fentanyl transdermal system and Flonase. It is created by eHealthMe based on reports of 20 people who take the same drugs from the FDA, and is updated regularly.

What is Fentanyl transdermal system?

Fentanyl transdermal system has active ingredients of fentanyl. It is often used in pain. eHealthMe is studying from 5,728 Fentanyl transdermal system users. Check the latest studies of Fentanyl transdermal system.

What is Flonase?

Flonase has active ingredients of fluticasone propionate. It is often used in allergies. eHealthMe is studying from 75,441 Flonase users. Check the latest studies of Flonase.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 28, 2026

20 people who take Fentanyl transdermal system and Flonase together, and have interactions are studied.

Fentanyl transdermal system and Flonase drug interactions.

What are the common drug interactions of Fentanyl Transdermal System and Flonase, by gender? *:

female:

  1. Application site pruritus (application site severe itching of the skin)
  2. Death
  3. Fall
  4. Herpes zoster
  5. Spinal compression fracture (fracture due to spinal compression on bone)
  6. Accidental exposure
  7. Adverse drug reaction
  8. Adverse event
  9. Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
  10. Conjunctivitis (pink eye)

male:

  1. Insomnia (sleeplessness)
  2. Application site irritation
  3. Malaise (a feeling of general discomfort or uneasiness)
  4. Muscle spasms (muscle contraction)
  5. Withdrawal syndrome (a discontinuation syndrome is a set of symptoms occurred due to discontinuation of substance)
  6. Adverse event
  7. Blood cholesterol increased
  8. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  9. Diarrhoea
  10. Hypertension (high blood pressure)

What are the common drug interactions of Fentanyl Transdermal System and Flonase, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Adverse event
  2. Blood cholesterol increased
  3. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  4. Hypertension (high blood pressure)
  5. Spinal cord compression
  6. Weight fluctuation
  7. Accidental exposure
  8. Application site rash
  9. Blood creatinine increased
  10. Conjunctivitis (pink eye)

50-59:

  1. Pneumonia
  2. Cold sweat
  3. Dysuria (painful or difficult urination)
  4. Eye disorder
  5. Gastric disorder (disease of stomach)
  6. Vitreous floaters (spots before the eyes)
  7. Adverse event
  8. Application site pruritus (application site severe itching of the skin)
  9. Disease progression
  10. Dizziness

60+:

  1. Death
  2. Application site pruritus (application site severe itching of the skin)
  3. Nausea (feeling of having an urge to vomit)
  4. Nervousness
  5. Pain in extremity
  6. Pain in jaw
  7. Pyrexia (fever)
  8. Rash macular (small, flat red spots)
  9. Rash maculo-papular (red area on the skin that is covered with small confluent bumps)
  10. Vomiting

What are the existing conditions these people have? *

  1. Multiple Allergies (allergy to multiple agents): 6 people, 30.00%
  2. Back Pain: 5 people, 25.00%
  3. Sleep Disorder: 5 people, 25.00%
  4. Breakthrough Pain: 4 people, 20.00%
  5. Depression: 4 people, 20.00%
  6. Diabetes: 3 people, 15.00%
  7. High Blood Pressure: 3 people, 15.00%
  8. Indigestion: 3 people, 15.00%
  9. Lung Disorder (lung disease): 2 people, 10.00%
  10. Asthma: 2 people, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take Fentanyl transdermal system and Flonase?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Fentanyl transdermal system and Flonase:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Fentanyl transdermal system:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Flonase:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Fentanyl transdermal system and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Flonase and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on fentanyl and fluticasone propionate (the active ingredients of Fentanyl transdermal system and Flonase, respectively), and Fentanyl transdermal system and Flonase (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: